Effectiveness of a Smartphone App for Adolescent Obesity Management
- Conditions
- ObesityPhysical ActivityImpaired HealthGeneral Nutrition DisorderPsychosocial Problem
- Interventions
- Behavioral: W82GODevice: smartphone application
- Registration Number
- NCT01804855
- Lead Sponsor
- Children's University Hospital, Ireland
- Brief Summary
Though face-to-face treatment of childhood obesity can be effective, it is time consuming and costly. This study will test whether treatment can be delivered via an Android app and whether such treatment reduces obesity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 126
- child aged between 12.0 and 17.0 years,
- child BMI =/> 98th percentile,
- first language is English (or fluent in English)
- parent/s willing to participate in the programme with their child
- completion of written informed consent and/or assent prior to any study-specific procedures
- severe intellectual difficulties,
- obesity secondary to genetic condition,
- limitations to engaging in physical activity
- use of medication known to effect body weight;
- limitations to using a smartphone device
- known family issues that would affect general compliance and attendance at follow-up visits.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description W82GO W82GO Usual face-to-face care as per the W82GO multidisciplinary treatment intervention (phase 1 for 6 weeks and phase 2 for 46 weeks). Smartphone smartphone application Usual care for Phase 1 of treatment. Treatment during Phase 2 of intervention using the Reactivate smartphone application only.
- Primary Outcome Measures
Name Time Method BMI Z score 12 months Z score calculated using LMS growth software
- Secondary Outcome Measures
Name Time Method Body Fat Mass 12 months Measured using Tanita Bioelectric impedance analyser
Physical activity 12 months Measured using Geneactive acclerometery
Laboratory tests 12 months Lipids; glucose; insulin; HbA1C; liver function
Safety 12 months Adverse effects will be monitored throughout the study and a full report at 12 months will be given.
Psychosocial health 12 months Measured using the Child Behaviour Check list
Trial Locations
- Locations (1)
Temple Street Children's University Hospital
🇮🇪Dublin, Ireland